• +1-646-491-9876
    • +91-20-67278686

    Search

    Hand, Foot and Mouth Disease - Pipeline Review, H1 2017

    Hand, Foot and Mouth Disease - Pipeline Review, H1 2017

    • Report Code ID: RW0001709472
    • Category Pharmaceuticals
    • No. of Pages 34
    • Publication Month Mar-17
    • Publisher Name Global Markets Direct
    Hand, Foot and Mouth Disease - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Hand, Foot and Mouth Disease - Pipeline Review, H1 2017, provides an overview of the Hand, Foot and Mouth Disease (Infectious Disease) pipeline landscape.

    Hand, foot and mouth disease is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease (HFMD) is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite and ulcers in the throat (including tonsils) , mouth, and tongue. Treatment includes antibiotics and pain relievers.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Hand, Foot and Mouth Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease (Infectious Disease) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I, Preclinical and Discovery stages are 1, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 2 molecules, respectively.

    Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Hand, Foot and Mouth Disease (Infectious Disease) .
    - The pipeline guide reviews pipeline therapeutics for Hand, Foot and Mouth Disease (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Hand, Foot and Mouth Disease (Infectious Disease) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Hand, Foot and Mouth Disease (Infectious Disease) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Hand, Foot and Mouth Disease (Infectious Disease)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Hand, Foot and Mouth Disease (Infectious Disease) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Hand, Foot and Mouth Disease (Infectious Disease) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Hand, Foot and Mouth Disease - Overview
    Hand, Foot and Mouth Disease - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    Hand, Foot and Mouth Disease - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Hand, Foot and Mouth Disease - Companies Involved in Therapeutics Development
    Adimmune Corp
    CJ HealthCare Corp
    Sentinext Therapeutics Sdn Bhd
    Takeda Pharmaceutical Company Ltd
    Hand, Foot and Mouth Disease - Drug Profiles
    (coxsackievirus [serotype A16] + enterovirus [serotype 71]) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CJ-40010 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    D-5 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    DC-07090 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Enterovirus [serotype EV-A71] (virus like particle, bivalent) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    hand, foot and mouth disease (viral like particle, bivalent) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Monoclonal Antibody for Hand, Foot and Mouth Disease - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules to Inhibit MAP2K1 for Hand, Foot and Mouth Disease - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    TAK-021 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Hand, Foot and Mouth Disease - Dormant Projects
    Hand, Foot and Mouth Disease - Product Development Milestones
    Featured News & Press Releases
    Mar 11, 2012: Inviragen Reports Top-Line Results From Phase I Trial Of INV21 Vaccine For Treatment Of Hand, Foot And Mouth Disease
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Hand, Foot and Mouth Disease, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Hand, Foot and Mouth Disease - Pipeline by Adimmune Corp, H1 2017
    Hand, Foot and Mouth Disease - Pipeline by CJ HealthCare Corp, H1 2017
    Hand, Foot and Mouth Disease - Pipeline by Sentinext Therapeutics Sdn Bhd, H1 2017
    Hand, Foot and Mouth Disease - Pipeline by Takeda Pharmaceutical Company Ltd, H1 2017
    Hand, Foot and Mouth Disease - Dormant Projects, H1 2017

    List of Figures

    Number of Products under Development for Hand, Foot and Mouth Disease, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Targets, H1 2017
    Number of Products by Stage and Targets, H1 2017
    Number of Products by Mechanism of Actions, H1 2017
    Number of Products by Stage and Mechanism of Actions, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    Adimmune Corp
    CJ HealthCare Corp
    Sentinext Therapeutics Sdn Bhd
    Takeda Pharmaceutical Company Ltd

    Request for Sample

    Report Url http://www.reportsweb.com//hand-foot-and-mouth-disease-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//hand-foot-and-mouth-disease-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//hand-foot-and-mouth-disease-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments